The development of immortalized cell lines has provided substantial progress in CF research, particularly for the understanding of CFTR biology, characterization of common and rare CF-causing mutations (and exclusion of non-pathogenic CFTR variants), and identification of novel CFTR modulator compounds. The gene discussed is CFTR; the disease is cystic fibrosis.